In Vitro and In Vivo Evaluation of the Effectiveness and Safety of Amygdalin As a Cancer Therapy

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Nov 10

PMID 36355478

Authors

Fatma I Abo El-Ela

Amr Gamal

Hossny Awad Elbanna

Ahmed H Elbanna

Heba F Salem

Alaa S Tulbah

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the most important causes of death worldwide. Several studies have shown the efficacy of apricot kernel seed as a cancer therapy due to the presence of amygdalin. These studies have demonstrated amygdalin's cytotoxicity, antioxidant activity, and apoptosis in vitro using human cancer cell lines. However, no studies have demonstrated their cancer activity in vivo. The aim of this study is to develop an amygdalin-loaded niosomes (ALN) gel formulation as a drug delivery system in order to investigate the selectivity, efficacy, and toxicity of amygdalin as a cancer therapy in vivo using the 7,12-dimethylbenz (a) anthracene (DMBA) carcinoma rat model. Based on pre-formulation studies, the ALN formulation composed of Tween 60: cholesterol: dihexadecyl phosphate in a molar ratio of 1:2:0.1 was chosen as an optimum formulation because it has a percent of EE of 66.52% with a particle size of 269.3 nm and a reflux of 3.54 µg.cm.h. The ALN gel formulation was integrated into carbopol gel to be evaluated in vivo. Compared to DMBA control, treatment with ALN gel showed a reduction in the carcinoma volume and in the hyperplasia of the epidermis with no signs of edema. In conclusion, the ALN gel formulation could be an efficient cancer therapy.

Citing Articles

Fabrication and In Vivo Evaluation of In Situ pH-Sensitive Hydrogel of Sonidegib-Invasomes via Intratumoral Delivery for Basal Cell Skin Cancer Management.

Ghalwash M, Fouad A, Mohammed N, Nagib M, Khalil S, Belal A Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861094 PMC: 11769384. DOI: 10.3390/ph18010031.

Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo Evaluation.

Farouk H, Nagib M, Fouad A, Naguib D, Khalil S, Belal A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598429 PMC: 11597612. DOI: 10.3390/ph17111518.

In Vitro and in vivo characterization of nasal pH-Responsive in-situ hydrogel of Candesartan-loaded invasomes as a potential stroke treatment.

El-Housiny S, Fouad A, El-Bakry R, Zaki R, Afzal O, Abo El-Ela F Drug Deliv Transl Res. 2024; .

PMID: 39259459 DOI: 10.1007/s13346-024-01700-z.

Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy.

Liga S, Paul C, Moaca E, Peter F Pharmaceutics. 2024; 16(2).

PMID: 38399277 PMC: 10892933. DOI: 10.3390/pharmaceutics16020223.

: a review on its botany, phytochemistry, pharmacology, clinical application, toxicology and pharmacokinetics.

Tang S, Wang M, Peng Y, Liang Y, Lei J, Tao Q Front Pharmacol. 2024; 15:1290888.

PMID: 38323080 PMC: 10844384. DOI: 10.3389/fphar.2024.1290888.

References

Lee H, Moon A . Amygdalin Regulates Apoptosis and Adhesion in Hs578T Triple-Negative Breast Cancer Cells. Biomol Ther (Seoul). 2016; 24(1):62-6. PMC: 4703354. DOI: 10.4062/biomolther.2015.172. View

Kwon Y, Ye D, Baek H, Chun Y . 7,12-Dimethylbenz[α]anthracene increases cell proliferation and invasion through induction of Wnt/β-catenin signaling and EMT process. Environ Toxicol. 2018; 33(7):729-742. DOI: 10.1002/tox.22560. View

Bishayee A, Sethi G . Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin Cancer Biol. 2016; 40-41:1-3. DOI: 10.1016/j.semcancer.2016.08.006. View

Shi J, Chen Q, Xu M, Xia Q, Zheng T, Teng J . Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review. Cancer Med. 2019; 8(6):3004-3011. PMC: 6558459. DOI: 10.1002/cam4.2197. View

Zaid Alkilani A, McCrudden M, Donnelly R . Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum. Pharmaceutics. 2015; 7(4):438-70. PMC: 4695828. DOI: 10.3390/pharmaceutics7040438. View

El-Masry T, Al-Shaalan N, Tousson E, Buabeid M, Al-Ghadeer A . Potential therapy of vitamin B17 against Ehrlich solid tumor induced changes in Interferon gamma, Nuclear factor kappa B, DNA fragmentation, p53, Bcl2, survivin, VEGF and TNF-α Expressions in mice. Pak J Pharm Sci. 2020; 33(1(Supplementary)):393-401. View

Dang T, Nguyen C, Tran P . Physician Beware: Severe Cyanide Toxicity from Amygdalin Tablets Ingestion. Case Rep Emerg Med. 2017; 2017:4289527. PMC: 5587935. DOI: 10.1155/2017/4289527. View

Witika B, Walker R . Preformulation characterization and identification of excipients for nevirapine loaded niosomes. Pharmazie. 2021; 76(2):77-83. DOI: 10.1691/ph.2021.0137. View

Wang Z, Zhang X . Chemopreventive Activity of Honokiol against 7, 12 - Dimethylbenz[a]anthracene-Induced Mammary Cancer in Female Sprague Dawley Rats. Front Pharmacol. 2017; 8:320. PMC: 5450001. DOI: 10.3389/fphar.2017.00320. View

10.

Abo El-Ela F, Hussein K, El-Banna H, Gamal A, Rouby S, Menshawy A . Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study. AAPS PharmSciTech. 2020; 21(8):326. DOI: 10.1208/s12249-020-01833-7. View

11.

Dandawate P, Subramaniam D, Jensen R, Anant S . Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Semin Cancer Biol. 2016; 40-41:192-208. PMC: 5565737. DOI: 10.1016/j.semcancer.2016.09.001. View

12.

Gamal A, Saeed H, Abo El-Ela F, Salem H . Improving the Antitumor Activity and Bioavailability of Sonidegib for the Treatment of Skin Cancer. Pharmaceutics. 2021; 13(10). PMC: 8537379. DOI: 10.3390/pharmaceutics13101560. View

13.

Al Shuwaili A, Abdul Rasool B, Abdulrasool A . Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur J Pharm Biopharm. 2016; 102:101-14. DOI: 10.1016/j.ejpb.2016.02.013. View

14.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

15.

Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C . DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010; 12(3):263-71. PMC: 2895453. DOI: 10.1208/s12248-010-9185-1. View

16.

Arafa M, Ayoub B . DOE Optimization of Nano-based Carrier of Pregabalin as Hydrogel: New Therapeutic &Chemometric Approaches for Controlled Drug Delivery Systems. Sci Rep. 2017; 7:41503. PMC: 5278417. DOI: 10.1038/srep41503. View

17.

Cassiem W, de Kock M . The anti-proliferative effect of apricot and peach kernel extracts on human colon cancer cells in vitro. BMC Complement Altern Med. 2019; 19(1):32. PMC: 6352493. DOI: 10.1186/s12906-019-2437-4. View

18.

Shankar E, Kanwal R, Candamo M, Gupta S . Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges. Semin Cancer Biol. 2016; 40-41:82-99. PMC: 5067170. DOI: 10.1016/j.semcancer.2016.04.002. View

19.

Kerdelhue B, Forest C, Coumoul X . Dimethyl-Benz(a)anthracene: A mammary carcinogen and a neuroendocrine disruptor. Biochim Open. 2018; 3:49-55. PMC: 5801823. DOI: 10.1016/j.biopen.2016.09.003. View

20.

He X, Wu L, Wang W, Xie P, Chen Y, Wang F . Amygdalin - A pharmacological and toxicological review. J Ethnopharmacol. 2020; 254:112717. DOI: 10.1016/j.jep.2020.112717. View